Page 2,776«..1020..2,7752,7762,7772,778..2,7902,800..»

Diet for Ulcerative colitis & Treatment – Video

Posted: Published on January 19th, 2015

Diet for Ulcerative colitis Treatment In Ulcerative colitis, the colon become inflamed. Ayurvedic treatment for ulcerative colitis along with advised diet is very effective. Advised Diet include,... By: Dr. Vikram Chauhan … Continue reading

Posted in Ulcerative Colitis | Comments Off on Diet for Ulcerative colitis & Treatment – Video

Duchenne muscular dystrophy drug could get OK for U.S. sales in 2016

Posted: Published on January 19th, 2015

A Northbrook company said it has won fast-track status for approval of a drug that could become the first in the United States to treat Duchenne muscular dystrophy, a fatal muscle disease found most often in boys. Privately held Marathon Pharmaceuticals said it hopes to win federal approval for deflazacort by 2016. About 20,000 boys and young men in the U.S. live with Duchenne, a progressive disease that's passed by mothers to sons but rarely to daughters, though the daughters can become carriers. It is characterized by a progressive loss of muscle strength, with many losing the ability to walk in their teens. Patients often die from respiratory or heart failure. Deflazacort, a steroid, has been shown to prolong lives as well as extend the ability to walk and breathe. But it is not a cure. It has been available in other countries such as Canada, Mexico and the United Kingdom for decades. U.S. Food and Drug Administration approval is eagerly awaited by people such as Ellen Wagner, whose son, Tim, was diagnosed at 2 with Duchenne. The McHenry mom began ordering deflazacort from the United Kingdom after the physician treating her son wrote a prescription. Its use in the … Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Duchenne muscular dystrophy drug could get OK for U.S. sales in 2016

Exalief (Eslicarbazepine Acetate) Soon to be Available in Russia as a Once Daily Adjunctive Treatment of Partial Onset …

Posted: Published on January 19th, 2015

Novel, anti-epilepsy treatment Exalief will soon be available in Russia. (Exalief is also marketed under the trade name Zebinix in Europe). Once-daily eslicarbazepine acetate is indicated in Europe as adjunctive therapy in adults with partial onset seizures, with or without secondary generalisation.[1] "Eslicarbazepine acetate will provide doctors with a new, easy to titrate, adjunctive therapy with a beneficial safety profile to help those with inadequately controlled partial onset epilepsy to improve their condition. Approximately one third of people with epilepsy do not achieve adequate control of epileptic seizures whilst taking their first antiepileptic drug, so there is a continued need for additional effective options," commented Professor Pavel Vlasov, Neurology and Neurosurgery department at the Moscow State University of Medicine and Stomatology. Epilepsy is one of the most common neurological conditions in the world.[2] Around three out of every 1,000 people in Russia live with the condition, 82% of which have partial epilepsy.[3] Despite many anti-epileptic drugs (AEDs) available, the successful treatment of partial onset seizures remains a significant challenge in some patients. Currently, between 20-40% of patients with newly diagnosed epilepsy will become refractory to treatment.[4] Eslicarbazepine acetate, a sodium channel blocker that differentially and selectively targets slow inactivated sodium … Continue reading

Comments Off on Exalief (Eslicarbazepine Acetate) Soon to be Available in Russia as a Once Daily Adjunctive Treatment of Partial Onset …

Circle of Care I Autism Channel I BHW – Video

Posted: Published on January 19th, 2015

Circle of Care I Autism Channel I BHW BHW is a premier autism treatment provider. More information at http://www.bhwcares.com About BHW: We help individuals with autism and other developmental disabilit... By: Behavioral Health Works (BHW) … Continue reading

Comments Off on Circle of Care I Autism Channel I BHW – Video

Researchers discover 'idiosyncratic' brain patterns in autism

Posted: Published on January 19th, 2015

IMAGE: Autism Spectrum Disorder (ASD) has been studied for many years, but there are still many more questions than answers. For example, some research into the brain functions of individuals with... view more Credit: Carnegie Mellon University PITTSBURGH-- Autism Spectrum Disorder (ASD) has been studied for many years, but there are still many more questions than answers. For example, some research into the brain functions of individuals with autism spectrum have found a lack of synchronization ('connectivity') between different parts of the brain that normally work in tandem. But other studies have found the exact opposite - over-synchronization in the brains of those with ASD. New research recently published in Nature Neuroscience suggests that the various reports -- of both over- and under-connectivity -- may, in fact, reflect a deeper principle of brain function. Led by scientists at the Weizmann Institute and Carnegie Mellon University, the study shows that the brains of individuals with autism display unique synchronization patterns, something that could impact earlier diagnosis of the disorder and future treatments. "Identifying brain profiles that differ from the pattern observed in typically developing individuals is crucial not only in that it allows researchers to begin to understand the differences that … Continue reading

Comments Off on Researchers discover 'idiosyncratic' brain patterns in autism

Catheter Stroke Treatment Can Fastrack Recovery, Study Finds

Posted: Published on January 19th, 2015

A recent study out shows that treatment now available to address the worst strokes actually is saving and bettering lives but notes there is still a ways to go before it will be offered broadly throughout the city. NY1's Erin Billups filed the following report. A study published in the New England Journal of Medicine says a new stroke treatment available is proven to help patients with the worst kind of strokes, shaving precious minutes and even hours off of response times. "My neighbor, she recognized that I was having a stroke and she called the ambulance. I was drooling at the mouth, and that my speech wasn't clear," says Maurice McConnell, a stroke patient. McConnell had a large clot preventing blood flow to the right side of his brain. Because he was on blood thinners the staff at Brookdale Hospital realized they couldn't treat him, so they transferred him to Lutheran Medical Center, one of three Advanced Comprehensive Stroke Centers in the city - a Joint Commission designation. "We've refined the process down to where we're trying very hard to bring these patients, from the time they hit the door to the time they're on our table to 90 … Continue reading

Comments Off on Catheter Stroke Treatment Can Fastrack Recovery, Study Finds

Mercy receives stroke care award

Posted: Published on January 19th, 2015

MASON CITY | Mercy Medical Center-North Iowa has received the Get With The Guidelines-Stroke Gold-Plus Quality Achievement Award for implementing specific quality-improvement measures outlined by the American Heart Association/American Stroke Association for the treatment of stroke patients. Get With The Guidelines Stroke helps hospital teams provide up-to-date research-based guidelines with the goal of speeding recovery and reducing death and disability for stroke patients, according to a news release. Mercy-North Iowa earned the award by meeting specific measures for the rapid diagnosis and treatment of stroke patients at a set level for a designated period, according to the news release. These measures include aggressive use of medications and risk-reduction therapies aimed at reducing death and disability and improving the lives of stroke patients. "Mercy is dedicated to improving the quality of stroke care and the American Heart Association/American Stroke Associations Get With The GuidelinesStroke helps us achieve that goal, said Dr. Alireza Yarahmadi, neurologist and medical director of the Mercy Stroke Center. With this award, our hospital demonstrates our commitment to ensure that our patients receive care based on internationally-respected clinical guidelines. View original post here: Mercy receives stroke care award … Continue reading

Comments Off on Mercy receives stroke care award

Neuropore, UCB partner to develop new treatment for Parkinsons disease

Posted: Published on January 19th, 2015

PBR Staff Writer Published 19 January 2015 US-based Neuropore Therapies has entered into a nagreement with Belgian biopharmaceutical firm UCB to develop and commercialize therapeutic products to slow the progression of Parkinsons disease (PD) and related disorders. As part of the deal, UCB will receive the world-wide exclusive license to develop and commercialize Neuropore's new small molecule NPT200-11in all indications. NPT200-11 that targets pathogenic alpha-synuclein which is currently in preclinical development and the companies will work together to complete non-clinical studies, with the first Phase I trial scheduled to be started in 2015. UCB New Medicines president Ismail Kola said: "Parkinson's disease is a debilitating neurodegenerative disorder that results in disruption of normal movement and motor function, as well as cognitive and other life-altering symptoms. "People living with Parkinson's disease need better treatment options, especially as there is currently no approved treatment that addresses a fundamental pathological mechanism in Parkinson's disease. "With Neuropore's NPT200-11, we have the opportunity to develop a disease modifying treatment option for patients with Parkinson's disease and other synucleinopathies." The deal will see an initial upfront payment of $20m made to Neuropore, which is also entitled to potential development, regulatory and sales-based milestones payments, of up … Continue reading

Posted in Parkinson's Treatment | Comments Off on Neuropore, UCB partner to develop new treatment for Parkinsons disease

Anna Hazare Gives Her Silent Treatment, Kiran Bedi Says She Will Explain

Posted: Published on January 19th, 2015

New Delhi: Kiran Bedi today said she would meet Anna Hazare and explain her decision to join politics. The 77-year-old Gandhian has refused to take Ms Bedi's calls, apparently upset that she did not consult him before joining the BJP. "I am not upset because Anna does not know why I have taken on this mantle," Kiran Bedi told NDTV in an exclusive interview, pointing at her saffron scarf with the BJP's lotus symbol. "The moment Anna knows that this for me is supreme giving.., the ultimate giving. It was time to give myself ultimately for India first and Delhi," she said. She added that she planned to meet Anna as soon as possible. "When I can go is a matter of time. First things first," she said, indicating that she wanted to finish with her campaign for the February 7 Delhi assembly polls before making that trip to Anna's hometown Ralegan Siddhi in Maharashtra. Sources say Anna Hazare has not taken Kiran Bedi's calls since Thursday, when she joined the BJP, as he feels "hurt." Ms Bedi has repeatedly called Mr Hazare repeatedly on the weekend, sources said. "I called Anna-ji on the telephone; sometimes he was sleeping and … Continue reading

Posted in MS Treatment | Comments Off on Anna Hazare Gives Her Silent Treatment, Kiran Bedi Says She Will Explain

Doctor quizzed on fallopian clip

Posted: Published on January 19th, 2015

A woman has described waking up from an operation to find both her fallopian tubes had been clipped without her consent. Lorna McKeogh had agreed to the clipping of one tube but, after the operation, was told by consultant obstetrician and gynaecologist Declan Egan: What did you want me to do, stitch it back up, wake you up, and ask for your permission? Dr Egan, of Dangan, Co Galway, faces one allegation of poor professional performance at a Medical Council fitness-to-practice inquiry in relation to the procedure he carried out on Ms McKeogh on June 2, 2010, at University College Hospital Galway. He denies the allegation and his barrister said Dr Egan believed this was the best course of treatment for Ms McKeogh. Ms McKeogh told the inquiry she was referred for a laproscopy after she had a number of miscarriages. It was found that she had a hydrosalpinx (a collection of fluid) of her right fallopian tube. Since this was toxic to the embryo, Ms McKeogh was told the tube may have to be clipped to allow her to bear an embryo to full term. She said she was referred to Dr Egan because her own obstetrician could not … Continue reading

Posted in MS Treatment | Comments Off on Doctor quizzed on fallopian clip

Page 2,776«..1020..2,7752,7762,7772,778..2,7902,800..»